Related Experiment Video
Updated: May 16, 2025

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
C/EBPβ activation in vascular smooth muscle cells promotes hyperlipidemia-induced phenotypic transition and arterial
Jun Ma1, Xiangyu Yang1, Yanan Li1
1Department of Cardiology, West China Hospital, Sichuan University, Sichuan, China.
Insights
CCAAT/enhancer-binding protein β (C/EBPβ) activation drives vascular smooth muscle cell changes, contributing to arterial stiffness in hyperlipidemia. This protein may offer new therapeutic targets and biomarkers for cardiovascular disease.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Vascular Cell Biology
Background:
- Arterial stiffness is a key risk factor for cardiovascular events, lacking specific clinical targets.
- Hyperlipidemia is strongly linked to arterial stiffness, with elevated CCAAT/enhancer-binding protein β (C/EBPβ) observed in atherosclerotic arteries.
- The role of C/EBPβ in vascular smooth muscle cells (VSMCs) during hyperlipidemia was previously unknown.
Purpose of the Study:
- To investigate the role of C/EBPβ in VSMCs under hyperlipidemic conditions.
- To elucidate the molecular mechanisms linking hyperlipidemia, VSMC changes, and arterial stiffness.
- To identify potential therapeutic targets and biomarkers for hyperlipidemia-induced arterial stiffness.
Main Methods:
- Examined cholesterol-induced phenotypic transition of VSMCs in vitro.
- Analyzed C/EBPβ expression and activation in relation to cytoskeletal regulation via Disheveled-associated activator of morphogenesis 1 (Daam1).
- Utilized conditional knockout of C/EBPβ in VSMCs of ApoE-/- mice to assess effects on vascular remodeling and pulse wave velocity.
- Correlated C/EBPβ-regulated platelet-derived growth factor-CC (PDGF-CC) with human brachial-ankle pulse wave velocity.
Main Results:
- Cholesterol induced a VSMC transition to macrophage-like cells, associated with C/EBPβ upregulation and activation.
- C/EBPβ activation, linked to Daam1 and cytoskeletal regulation, promoted VSMC phenotypic switching.
- Conditional C/EBPβ knockout in ApoE-/- mice reduced vascular remodeling and aortic pulse wave velocity.
- Elevated PDGF-CC, regulated by C/EBPβ, correlated with human brachial-ankle pulse wave velocity.
Conclusions:
- C/EBPβ activation promotes VSMC transition to a macrophage-like phenotype, contributing to hyperlipidemia-induced arterial stiffness.
- PDGF-CC is a potential biomarker for arterial stiffness in humans.
- This study reveals key molecular pathways and potential targets for managing arterial stiffness in hyperlipidemia.
Abstract:
Arterial stiffness is a critical factor in cardiovascular and cerebrovascular events, yet clinical practice lacks specific therapeutic targets and biomarkers for its assessment. Hyperlipidemia closely correlates with arterial stiffness, and we observed elevated CCAAT/enhancer-binding protein β (C/EBPβ) expression in atherosclerotic mouse arterial walls. As the arterial medial layer predominantly consists of vascular smooth muscle cells (VSMCs), C/EBPβ's role in VSMCs under hyperlipidemia remains unclear. Our findings demonstrate that cholesterol-induced phenotypic transition of contractile VSMCs to macrophage-like cells coincides with C/EBPβ upregulation and activation. The activation of C/EBPβ is closely related to cellular assembly and organization, regulating the cytoskeleton via Disheveled-associated activator of morphogenesis 1 (Daam1). Conditional knockout of C/EBPβ in VSMCs of ApoE-/- mice alleviated hyperlipidemia-induced vascular remodeling and reduced the elevation of aortic pulse wave velocity. Additionally, C/EBPβ-regulated cytokine platelet-derived growth factor-CC (PDGF-CC) is correlated with brachial-ankle pulse wave velocity in humans. These results indicate that the activation of C/EBPβ promotes the transition of VSMCs from a contractile phenotype to a macrophage-like phenotype by regulating morphological changes, and C/EBPβ activation contributes to hyperlipidemia-induced arterial stiffness. PDGF-CC exhibited a significant association with arterial stiffness and may serve as a promising indicator of arterial stiffness in humans. Our study reveals molecular mechanisms behind hyperlipidemia-induced arterial stiffness and provides potential therapeutic targets and biomarkers.
More Related Videos
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Cholesterol: Significance and Regulation
Considering cholesterol and...
Inflammation
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
cAMP-dependent Protein Kinase Pathways
Antihypertensive Drugs: Action of Calcium Channel Blockers

